BRIEF published on 08/26/2026 at 17:50, 15 days 7 hours ago Mauna Kea Technologies: Advances in the diagnosis of digestive cancers Mauna Kea Technologies Endomicroscopy Meta-analysis NECA Digestive Cancers
BRIEF published on 08/26/2026 at 17:50, 15 days 7 hours ago Mauna Kea Technologies Highlights Meta-Analysis on Cellvizio's Clinical Impact Mauna Kea Technologies Cellvizio Meta-analysis Upper Gastrointestinal Cancer PCLE
PRESS RELEASE published on 08/26/2026 at 17:45, 15 days 7 hours ago Inside Information / Other news releases Mauna Kea Technologies announces publication of a landmark systematic review and meta-analysis reinforcing the diagnostic accuracy and clinical impact of Cellvizio in upper gastrointestinal cancer Mauna Kea Technologies Cellvizio Meta-analysis Upper Gastrointestinal Cancer Systematic Review
BRIEF published on 08/07/2026 at 17:50, 1 month 3 days ago Mauna Kea Technologies Reports Voting Rights and Share Capital Details Share Capital Voting Rights Euronext Growth AMF Regulations Mauna Kea Technologies
BRIEF published on 08/07/2026 at 17:50, 1 month 3 days ago Mauna Kea Technologies: Voting rights and share capital as of July 31, 2026 Share Capital Voting Rights AMF Euronext Growth Mauna Kea Technologies
PRESS RELEASE published on 08/07/2026 at 17:45, 1 month 3 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Mauna Kea Technologies provides monthly information on voting rights and shares. Cellvizio platform revolutionizing medical diagnostics worldwide Voting Rights Shares Medical Diagnostics Mauna Kea Technologies Cellvizio Platform
BRIEF published on 07/16/2026 at 18:01, 1 month 25 days ago Mauna Kea Technologies to Host a Webinar on First-Half 2026 Business Activity Webinar Financial Community Business Highlights Mauna Kea Technologies Cellvizio®
BRIEF published on 07/16/2026 at 18:01, 1 month 25 days ago Mauna Kea Technologies videoconference on the first half of 2026 Shareholders Vidéo Conférence Mauna Kea Technologies Cellvizio® First Half Of 2026
PRESS RELEASE published on 07/16/2026 at 17:56, 1 month 25 days ago Inside Information / Other news releases Mauna Kea Technologies to host a webinar on July 21, 2026 to discuss its first-half business activity. Sacha Loiseau and Côme de La Tour du Pin will provide live commentary and Q&A session Medical Device Webinar Mauna Kea Technologies Cellvizio Business Activity
BRIEF published on 07/15/2026 at 19:49, 1 month 26 days ago Mauna Kea Technologies secures €4 million in funding Funding Cash Management Internationalization Cellvizio® Vester Finance
Published on 09/10/2026 at 22:25, 2 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 9 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 10 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/10/2026 at 14:37, 10 hours 23 minutes ago Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Published on 09/10/2026 at 22:39, 2 hours 20 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 2 hours 49 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 2 hours 53 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/10/2026 at 19:30, 5 hours 30 minutes ago Availability of the 2026 Interim Financial Report
Published on 09/09/2026 at 17:45, 1 day 7 hours ago Information concerning the total number of voting rights and shares 2026 08 31
Published on 09/09/2026 at 17:45, 1 day 7 hours ago Report on share repurchases from 7 to 8 September 2026
